These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 22289725)

  • 1. Evaluation of the National Heart, Lung, and Blood Institute guidelines impairment domain for classifying asthma control and predicting asthma exacerbations.
    Zeiger RS; Yegin A; Simons FE; Haselkorn T; Rasouliyan L; Szefler SJ; Chipps BE;
    Ann Allergy Asthma Immunol; 2012 Feb; 108(2):81-7. PubMed ID: 22289725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent asthma exacerbations: a key predictor of future exacerbations.
    Miller MK; Lee JH; Miller DP; Wenzel SE;
    Respir Med; 2007 Mar; 101(3):481-9. PubMed ID: 16914299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic burden of impairment in children with severe or difficult-to-treat asthma.
    Szefler SJ; Zeiger RS; Haselkorn T; Mink DR; Kamath TV; Fish JE; Chipps BE
    Ann Allergy Asthma Immunol; 2011 Aug; 107(2):110-119.e1. PubMed ID: 21802018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical burden and predictors of asthma exacerbations in patients on guideline-based steps 4-6 asthma therapy in the TENOR cohort.
    Calhoun WJ; Haselkorn T; Mink DR; Miller DP; Dorenbaum A; Zeiger RS
    J Allergy Clin Immunol Pract; 2014; 2(2):193-200. PubMed ID: 24607048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subacute lack of asthma control and acute asthma exacerbation history as predictors of subsequent acute asthma exacerbations: evidence from managed care data.
    O'Connor RD; Bleecker ER; Long A; Tashkin D; Peters S; Klingman D; Gutierrez B
    J Asthma; 2010 May; 47(4):422-8. PubMed ID: 20528597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The exacerbation component of impairment and risk in pediatric asthma.
    Bloomberg GR
    Curr Opin Allergy Clin Immunol; 2010 Apr; 10(2):155-60. PubMed ID: 20010093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current asthma control predicts future risk of asthma exacerbation: a 12-month prospective cohort study.
    Wei HH; Zhou T; Wang L; Zhang HP; Fu JJ; Wang L; Ji YL; Wang G
    Chin Med J (Engl); 2012 Sep; 125(17):2986-93. PubMed ID: 22932168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma.
    Blanchette CM; Culler SD; Ershoff D; Gutierrez B
    Clin Ther; 2009 Nov; 31(11):2574-83. PubMed ID: 20110003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Change in asthma control over time: predictors and outcomes.
    Schatz M; Zeiger RS; Yang SJ; Chen W; Crawford W; Sajjan S; Allen-Ramey F
    J Allergy Clin Immunol Pract; 2014; 2(1):59-64. PubMed ID: 24565770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High blood eosinophil count is a risk factor for future asthma exacerbations in adult persistent asthma.
    Zeiger RS; Schatz M; Li Q; Chen W; Khatry DB; Gossage D; Tran TN
    J Allergy Clin Immunol Pract; 2014; 2(6):741-50. PubMed ID: 25439366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of risk factors and health outcomes among persons with asthma.
    Smith K; Warholak T; Armstrong E; Leib M; Rehfeld R; Malone D
    J Asthma; 2009 Apr; 46(3):234-7. PubMed ID: 19373629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consistently very poorly controlled asthma, as defined by the impairment domain of the Expert Panel Report 3 guidelines, increases risk for future severe asthma exacerbations in The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study.
    Haselkorn T; Fish JE; Zeiger RS; Szefler SJ; Miller DP; Chipps BE; Simons FE; Weiss ST; Wenzel SE; Borish L; Bleecker ER;
    J Allergy Clin Immunol; 2009 Nov; 124(5):895-902.e1-4. PubMed ID: 19811812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of weight change on asthma-related health outcomes in patients with severe or difficult-to-treat asthma.
    Haselkorn T; Fish JE; Chipps BE; Miller DP; Chen H; Weiss ST
    Respir Med; 2009 Feb; 103(2):274-83. PubMed ID: 18819787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE.
    Humbert M; Beasley R; Ayres J; Slavin R; Hébert J; Bousquet J; Beeh KM; Ramos S; Canonica GW; Hedgecock S; Fox H; Blogg M; Surrey K
    Allergy; 2005 Mar; 60(3):309-16. PubMed ID: 15679715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
    Maspero J; Guerra F; Cuevas F; Gutierrez JP; Soto-Ramos M; Anderton S; Mechali D; Chan R; Pedersen S
    Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exhaled nitric oxide as a predictor of exacerbation in children with moderate-to-severe asthma: a prospective, 5-month study.
    Cabral AL; Vollmer WM; Barbirotto RM; Martins MA
    Ann Allergy Asthma Immunol; 2009 Sep; 103(3):206-11. PubMed ID: 19788017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Childhood Asthma Control Test: retrospective determination and clinical validation of a cut point to identify children with very poorly controlled asthma.
    Liu AH; Zeiger RS; Sorkness CA; Ostrom NK; Chipps BE; Rosa K; Watson ME; Kaplan MS; Meurer JR; Mahr TA; Blaiss MS; Piault-Louis E; McDonald J
    J Allergy Clin Immunol; 2010 Aug; 126(2):267-73, 273.e1. PubMed ID: 20624640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting an asthma exacerbation in children 2 to 5 years of age.
    Swern AS; Tozzi CA; Knorr B; Bisgaard H
    Ann Allergy Asthma Immunol; 2008 Dec; 101(6):626-30. PubMed ID: 19119707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The strategy for predicting future exacerbation of asthma using a combination of the Asthma Control Test and lung function test.
    Sato R; Tomita K; Sano H; Ichihashi H; Yamagata S; Sano A; Yamagata T; Miyara T; Iwanaga T; Muraki M; Tohda Y
    J Asthma; 2009 Sep; 46(7):677-82. PubMed ID: 19728204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quarterly assessment of short-acting beta(2)-adrenergic agonist use as a predictor of subsequent health care use for asthmatic patients in the United States.
    Silver HS; Blanchette CM; Kamble S; Petersen H; Letter M; Meddis D; Gutierrez B
    J Asthma; 2010 Aug; 47(6):660-6. PubMed ID: 20615167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.